Estrella Immunopharma, Inc. (ESLA) Deferred Income Tax Liabilities, Net USD 2022 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Estrella Immunopharma, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from 2022 to 2023.
  • Estrella Immunopharma, Inc. Deferred Income Tax Liabilities, Net for the quarter ending June 30, 2023 was $8.37 K.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $8.37 K Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $7.77 K Mar 31, 2023 10-Q 2023-05-18
Q4 2022 $29.5 K Dec 31, 2022 10-Q 2023-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.